Up next

Autoplay

Pure erythroid leukaemias

4 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Dr Montalbán Bravo meets with ecancertv at ASH 2016 to discuss the aetiology and prognostic outlook of pure erythroid leukaemia, a subset of acute leukaemia.

He discusses the cell lineage of the disease, and describes sequencing data helping to form a greater genetic and biological understanding of PEL and its treatment choices.

Dr Montalbán Bravo also spoke with ecancer about the clinical utility of guadecitabine and azacitadine plus verinostat.

Show more
0 Comments sort Sort By
Facebook Comments